Please login to the form below

Not currently logged in
Email:
Password:

Prostvac

This page shows the latest Prostvac news and features for those working in and with pharma, biotech and healthcare.

AZ’s Imfinzi paired with Bavarian Nordic’s CV301 vaccine

AZ’s Imfinzi paired with Bavarian Nordic’s CV301 vaccine

CV301 is Bavarian Nordic’s lead cancer vaccine after its much-delayed Prostvac candidate for prostate cancer failed to meet the mark in a phase III trial last year, wreaking havoc ... The setback was also a big disappointment for Bristol-Myers Squibb

Latest news

  • BMS signs $975m deal for Bavarian Nordic cancer vaccine BMS signs $975m deal for Bavarian Nordic cancer vaccine

    BMS signs $975m deal for Bavarian Nordic cancer vaccine. Furthers prominent position in immuno-oncology with Prostvac. ... Bristol-Myers Squibb has consolidated its position in the emerging immuno-oncology sector with a $975m deal to license Bavarian

  • Developing therapeutic cancer vaccines Developing therapeutic cancer vaccines

    Viral-vector based vaccines are also in the works. BN ImmunoTherapeutics and the US NCI are developing a viral-vector based vaccine, rilimogene galvacirepvec-rilimogene glafolivec (PROSTVAC), which is in phase

  • New hope for castration-resistant prostate cancer New hope for castration-resistant prostate cancer

    A recombinant pox virus vaccine encoding human PSA called rilimogene galvacirepvec-rilimogene glafolivec (Prostvac; BN ImmunoTherapeutics, US National Cancer Institute) is another immunotherapeutic agent in phase III development for metastatic CRPC.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics